0:00:00 | however |
---|
0:00:01 | i'm stepping injuries |
---|
0:00:03 | and like to tell you briefly about the paper read a whole than i have |
---|
0:00:07 | written |
---|
0:00:09 | characteristics in management of a new related adverse impacts associated with it will now and |
---|
0:00:14 | you in their be formatted static melanoma |
---|
0:00:18 | just a little background |
---|
0:00:20 | when diagnosed in the early stages melanoma is highly treatable and associated with good long-term |
---|
0:00:25 | l |
---|
0:00:27 | however for patients diagnosed with it being instrument a static melanoma |
---|
0:00:31 | the prognosis is much or |
---|
0:00:34 | and you in you know therapeutic agent it a little map has been approved for |
---|
0:00:38 | the treatment of a payments are made a static melanoma |
---|
0:00:42 | it is been shown to significantly improve overall survival intonation |
---|
0:00:46 | but it will in the map can also cause i mean related adverse to |
---|
0:00:51 | or only or a e |
---|
0:00:53 | and are unlikely tight if you little amount of meaning related mechanism of action |
---|
0:00:58 | are paper discusses the most common i already and how to manage the of the |
---|
0:01:03 | so that patients can stay on their t and hopefully have a successful outcome |
---|
0:01:09 | when the map is in the start as a ninety minute intravenous infusions and a |
---|
0:01:14 | dose of three milligrams per kilogram every three weeks for four doses over a period |
---|
0:01:18 | of twelve week |
---|
0:01:20 | the most common i are eighties include toxicity is that this again gastrointestinal tract |
---|
0:01:26 | integrated system in liver |
---|
0:01:28 | let's come and higher rate easing clean neurological ocular |
---|
0:01:32 | overall the original and prompt intervention and the use of cortical steroids have been successful |
---|
0:01:38 | in clinical trials to manage higher at |
---|
0:01:41 | timed onset of i r a you can be re |
---|
0:01:44 | but most occur within the first well we face actually |
---|
0:01:48 | however some can be seen as early as following the first rate |
---|
0:01:52 | especially in the case of dermatological |
---|
0:01:55 | others can occur for weeks or even not activation completed their p |
---|
0:02:00 | especially as seen in the case of integrated |
---|
0:02:04 | you're great events occur in lemma map may need to be withheld or even remotely |
---|
0:02:09 | discontinue |
---|
0:02:10 | but in many cases i already is can be successfully managed impatient can continue air |
---|
0:02:16 | e |
---|
0:02:17 | in our paper we were you for cases to illustrate the management for the most |
---|
0:02:21 | common types that i are at the intonation |
---|
0:02:25 | these are immune related german titus |
---|
0:02:28 | intra collided hepatitis endangered or not |
---|
0:02:32 | i had a spatial the stage for melanoma accuracy three times as the baby limit |
---|
0:02:36 | mapping presented with them terms of severe fifty headache in cognitive dysfunction |
---|
0:02:42 | even though brehm a task this is the first consideration a prophesy they should also |
---|
0:02:47 | be considered as anyone that is received little now |
---|
0:02:51 | and the brain would be to terry should be order to assess for pituitary swelling |
---|
0:02:57 | as well as lab worked with that's pituitary gland |
---|
0:03:01 | this case is one of four percent in our paper along with more detailed information |
---|
0:03:05 | on the specific the management of that type of i r a e |
---|
0:03:10 | to conclude it really matters than a whole f t i approved in you know |
---|
0:03:14 | they're a chipper and respectable and then a static melanoma |
---|
0:03:18 | due to its characteristic distinctive mechanism of action |
---|
0:03:22 | it being the map elicit a number of specific i alright he's |
---|
0:03:26 | expedient in careful recognition monitoring of i are eighties that may occur during treatment would |
---|
0:03:31 | it be little about |
---|
0:03:33 | male how patients to continue to benefit from their p |
---|
0:03:36 | and optimize |
---|
0:03:39 | i hope you find this helpful |
---|
0:03:41 | thank you for listening |
---|